Preclinical & Clinical Development Services 〔海外情報〕
|
Contract Research Expert to Lead Expansion of Millipore BioPharma Services May 2009: Millipore Corporation announces James Hulse, Ph.D. as the Director of Biomarker Services Business Development. Read more... |
Our Regulatory Compliant Laboratory (RCL) is a CRO leader in the development, validation and application of ligand binding assays enabling development of biopharmaceuticals and translational biomarker applications. The RCL designs, develops, optimizes and validates analytical techniques for pharmacokinetic assessments of biotherapeutics, determination of novel biomarkers, and detection of anti-drug antibodies (immunogenicity testing). These activities comply with regulatory expectations (CLIA, GLP, OECD), including computer validation (21 CFR Part 11) and oversight by our Quality Assurance unit.
| | Millipore Acquires BioAnaLabMillipore and BioAnaLab Limited have joined forces to strengthen the scientific expertise available to both Millipore and BioAnaLab customers in Europe and North America. With this acquisition, Millipore has solidified its leading position in the large molecule bioanalytical market and has expanded its BioPharma Services portfolio. » Learn more...
|
